These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11332558)

  • 21. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transvenous defibrillation leads: high incidence of failure during long-term follow-up.
    Dorwarth U; Frey B; Dugas M; Matis T; Fiek M; Schmoeckel M; Remp T; Durchlaub I; Gerth A; Steinbeck G; Hoffmann E
    J Cardiovasc Electrophysiol; 2003 Jan; 14(1):38-43. PubMed ID: 12625608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rate and coupling interval on endocardial R wave amplitude variability in permanent ventricular sensing lead systems.
    Callans DJ; Hook BG; Marchlinski FE
    J Am Coll Cardiol; 1993 Sep; 22(3):746-50. PubMed ID: 8354808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial.
    Gold MR; Ahmad S; Browne K; Berg KC; Thackeray L; Berger RD
    Heart Rhythm; 2012 Mar; 9(3):370-7. PubMed ID: 21978966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
    Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
    Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter defibrillator system: incidence and clinical significance.
    Rosenthal ME; Paskman C
    Pacing Clin Electrophysiol; 1998 Jul; 21(7):1380-6. PubMed ID: 9670181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator.
    Ajiro Y; Shiga T; Shoda M; Hagiwara N
    Heart Vessels; 2017 Mar; 32(3):364-368. PubMed ID: 27576324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator.
    Egan P; Wilkoff BL; Tchou P
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recording of pacing stimulus artifacts by endovascular defibrillation lead systems: comparison of true and integrated bipolar circuits.
    Menz V; Schwartzman D; Drachman D; Michele JJ; Dillon SM
    J Interv Card Electrophysiol; 1998 Sep; 2(3):269-72. PubMed ID: 9870021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
    Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
    Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of bradycardia pacing and detection of ventricular fibrillation due to far-field atrial sensing in a triple chamber implantable cardioverter defibrillator.
    Vollmann D; Lüthje L; Görtler G; Unterberg C
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1513-6. PubMed ID: 12418750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the AutoCapture Pacing System with implantable defibrillator leads.
    Marenco JP; Greenfield RA; Massumi A; Syed ZA; Mcintyre T; Hardage M; Link MS; Homoud MK; Estes M; Wang PJ
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):471-3. PubMed ID: 12687870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inappropriate discharge of an implantable cardioverter defibrillator during atrial flutter and intermittent ventricular antibradycardia pacing.
    Peters W; Kowallik P; Wittenberg G; Scholl C; Meesmann M
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1167-74. PubMed ID: 9363821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.
    Kühlkamp V;
    J Am Coll Cardiol; 2002 Mar; 39(5):790-7. PubMed ID: 11869843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.
    Singer I; Adams L; Austin E
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1070-9. PubMed ID: 7685888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.